COVID-19: revaccination and variant vaccines

Vaccination against COVID-19 has saved millions of lives so far. But, there are many problems implementing worldwide vaccination such as production, distribution, cost and vaccine hesitancy issues. Beyond that, at this stage of the pandemic, the world must decide:
• Do we need booster doses?
• Are original vaccines effective or do we need variant vaccines?
• What are those variant vaccines?
Experts in the field discussed these timely and important questions in ISAC's recent webinar.
00:00 Start
00:02 Introduction - Prof. Serhat Unal
08:00 Revaccination in COVID-19 - Prof. Rafael Araos
43:43 Inactivated vaccines - Dr Eric Gao
1:10:40 mRNA vaccines - Dr Sultan Abduljawad
1:30:30 Vector Vaccines - Dr Bárbara Emoingt Furtado
Disclaimer
The webinars / lectures provided by the International Society of Antimicrobial Chemotherapy (ISAC) are for informational purposes only. No material contained herein is intended to be a substitute for professional medical advice, diagnosis, treatment or national / local guidelines.
The opinions expressed in a webinar are those of the author(s) only and may not necessarily represent the views of ISAC. Where links are provided to other sites and resources of third parties, these links are provided for your information only. ISAC neither endorses not accepts responsibility for the contents of those sites or resources.